News related to Bexxar (Tositumomab / Iodine I 131 Tositumomab) and/or conditions it is approved for
Lymphoma Association Launches New Short Film
Source: Blood / Hematology News From Medical News Today [2008.11.20]
The Lymphoma Association is delighted to launch their latest short film which shows the services they offer to anyone affected by lymphoma - the UK's sixth most common cancer. The charity were selected to have the film made for them for a nominal fee by the Media Trust, an organisation which helps charities raise awareness by providing them with volunteers from the TV, film and video industry who then produce videos for them.
Researchers Aim To Over-stress Already Taxed Mantle Cell Lymphoma Cells
Source: Blood / Hematology News From Medical News Today [2008.11.11]
Cancer cells are already stressed by the fast pace they require to grow and spread and scientists believe a little more stress just may kill them. "Think about an assembly line in a factory that is working five times faster than normal," said Dr. Kapil Bhalla, director of the Medical College of Georgia Cancer Center. "There is a lot of stress but you need workers to keep going. Some of them fall out, some get bent out of shape.
National Gala Raises Over $1.15 Million For Lymphoma-Focused Research - Guests Vote To Eradicate Lymphoma
Source: Lymphoma / Leukemia News From Medical News Today [2008.11.10]
Over 520 guests reached into their pockets to the tune of over $1.15 million and cast their vote for increased funding for lymphoma-focused research at Vote For A Cure: the Lymphoma Research Foundation's (LRF) 2008 National Gala held on October 6 at the New York Marriot Marquis. Tom Brokaw, NBC News, shared emcee duties with Jeff Greenfield of CBS News for this very successful event.
CIGNA To Promote The Leukemia & Lymphoma Society's Co-Pay Assistance Program, USA
Source: Lymphoma / Leukemia News From Medical News Today [2008.11.07]
CIGNA Pharmacy Management (CIGNA) and the Leukemia & Lymphoma Society (LLS) are joining forces to promote LLS's efforts to help blood cancer patients cover the costs of prescription co-pays and health insurance premiums. The costs of cancer are significant. According to the National Cancer Institute, direct medical costs for cancer care in 2004 totaled more than $72 billion.
Silicone Breast Implants Might Raise Risk of Rare Lymphoma
Source: MedicineNet Hodgkins Disease Specialty [2008.11.05]
Title: Silicone Breast Implants Might Raise Risk of Rare Lymphoma
Category: Health News
Created: 11/5/2008 2:00:00 AM
Last Editorial Review: 11/5/2008
Silicone Breast Implants Might Raise Risk of Rare Lymphoma (HealthDay)
Source: Y! Health Lymphoma News [2008.11.04]
HealthDay - TUESDAY, Nov. 4 (HealthDay News) -- Women with silicone breast
implants may have a higher risk of developing a rare form of lymphoma, new
research suggests.
FDA Okays Chemotherapy Drug for Lymphoma
Source: MedPage Today Product Alert [2008.11.03]
FRANZER, Pa. (MedPage Today) -- The FDA has approved bendamustine hydrochloride (Treanda) for use against indolent B-cell non-Hodgkin's lymphoma that has progressed within six months of treatment with a regimen including rituximab, Cephalon, maker of the drug, announced.
Socioeconomics play into lymphoma survival (Reuters)
Source: Y! Health Lymphoma News [2008.10.21]
Reuters - People with a type of cancer known as non-Hodgkin lymphoma, or NHL, are less likely to get appropriate treatment, and more likely to die of the disease, if they fall into a lower rather than higher socioeconomic level, a study in the journal Cancer shows.
Poverty Raises Mortality Risk With Non-Hodgkin Lymphoma
Source: MedicineNet Loss, Grief, and Bereavement Specialty [2008.10.21]
Title: Poverty Raises Mortality Risk With Non-Hodgkin Lymphoma
Category: Health News
Created: 10/21/2008 2:00:00 AM
Last Editorial Review: 10/21/2008
Ontak Approved to Treat T-Cell Lymphoma
Source: MedicineNet Edema Specialty [2008.10.20]
Title: Ontak Approved to Treat T-Cell Lymphoma
Category: Health News
Created: 10/18/2008 2:00:00 AM
Last Editorial Review: 10/20/2008
New Lymphoma Drug Shows Promise
Source: MedicineNet Hodgkins Disease Specialty [2008.08.15]
Title: New Lymphoma Drug Shows Promise
Category: Health News
Created: 8/15/2008 2:00:00 AM
Last Editorial Review: 8/15/2008
Incidence of Mantle Cell Lymphoma on Rise
Source: MedicineNet Hodgkins Disease Specialty [2008.07.21]
Title: Incidence of Mantle Cell Lymphoma on Rise
Category: Health News
Created: 7/19/2008 2:00:00 AM
Last Editorial Review: 7/21/2008
Non-Hodgkins Lymphomas
Source: MedicineNet Biological Therapy Specialty [2008.07.14]
Title: Non-Hodgkins Lymphomas
Category: Diseases and Conditions
Created: 12/31/1997
Last Editorial Review: 7/14/2008
Possible Cure for Rare Lymphoma Reported
Source: MedicineNet dexamethasone oral Specialty [2007.12.10]
Title: Possible Cure for Rare Lymphoma Reported
Category: Health News
Created: 12/10/2007 2:00:00 AM
Last Editorial Review: 12/10/2007
Breakthrough test clearly distinguishes Burkitt lymphoma from DLBCL
Source: The Doctors Lounge - Oncology
A gene expression signature clearly distinguishes Burkitt lymphoma from DLBCL, a critical distinction in diagnosis.
Cell Therapeutics' Pixantrone Phase III (EXTEND) Pivotal Trial Successful In Achieving Primary Endpoint
Source: Lymphoma / Leukemia News From Medical News Today [2008.11.12]
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced that it achieved the primary efficacy endpoint of its phase III EXTEND (PIX301) trial of pixantrone (BBR2778) for patients with advanced, relapsed aggressive non-Hodgkin's lymphoma (NHL) based on a preliminary intent to treat efficacy analysis.
Saving Lives Won't Get Lost In Translation
Source: Lymphoma / Leukemia News From Medical News Today [2008.11.05]
In an effort to recruit even more volunteer stem cell donors from varied ethnic communities, Canada's OneMatch Stem Cell and Marrow Network has begun to offer services in languages other than English and French. Today, more than 600 patients across Canada require a life-saving stem cell transplant for cancers such as leukemia, lymphoma and myeloma, as well as for other immune and genetic disorders.
Increased Cancer Risk Following Liver Transplant
Source: Colorectal Cancer News From Medical News Today [2008.11.04]
A new Canadian study comparing cancer rates of liver transplant patients to those of the general population has found that transplant recipients face increased risks of developing cancer, especially non-Hodgkin's lymphoma and colorectal cancer. Risks were more pronounced during the first year of follow-up and among younger transplant recipients. These findings are published in the November issue of Liver Transplantation, a journal by John Wiley & Sons.
Cell Therapeutics Announces Study Data Set Cut-off For Phase III Pivotal Pixantrone (301) Trial
Source: Lymphoma / Leukemia News From Medical News Today [2008.11.04]
Cell Therapeutics, Inc. (CTI) (Nasdaq and MTA: CTIC) announced that it has closed the data set for preliminary analysis of the primary endpoint in the phase III EXTEND (PIX301) trial of pixantrone (BBR2278) for patients with relapsed diffuse large B cell non-Hodgkin's lymphoma (NHL) and it has provided Novartis notice that the data set has been closed.
Breast implants may increase risk of rare cancer (Reuters)
Source: Y! Health Lymphoma News [2008.11.04]
Reuters - The results of a new study suggest that silicone breast prostheses may increase the risk of developing a rare form of lymphoma - cancer of the lymph system. However, the authors emphasize that because anaplastic large T-cell lymphoma (ALCL) of the breast is so rare, the absolute risk is still very low.
|
